Quantitative analysis for Clene Inc. (CLNN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (39.0) (grade D). 30 signals analyzed (25 differentiated alt-data).
CLNN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $6.21 | $5.85 | $5.85 |
| 2026-05-08 | $7.46 | $6.97 | $7.28 |
| 2026-05-20 | $6.90 | $6.32 | $6.90 |
| 2026-06-02 | $6.24 | $5.75 | $5.87 |
| 2026-06-12 | $5.89 | $5.41 | $5.84 |
| 2026-06-25 | $6.08 | $5.60 | $5.79 |
| 2026-07-08 | $6.21 | $6.00 | $6.08 |
| 2026-07-20 | $6.02 | $5.72 | $5.73 |
| 2026-07-30 | $5.13 | $4.78 | $5.04 |
| 2026-08-12 | $4.46 | $3.95 | $4.07 |
| 2026-08-24 | $4.53 | $4.30 | $4.43 |
| 2026-09-03 | $4.22 | $3.75 | $4.00 |
How Clene Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| RANI | Rani Therapeutics Holdings, Inc. | $71M | — |
| GANX | Gain Therapeutics, Inc. | $70M | — |
| CYPH | Cypherpunk Technologies Inc. | $72M | 38.0 |
| VANI | Vivani Medical, Inc. | $70M | — |
View all Health Care stocks by valuation and signals →
Clene Inc. (CLNN) scores Sell (39.0), and the composite conceals a 74-point disagreement between its dimensions. It is strongest on competitive moat at 98 and analyst consensus at 74, and weakest on technicals at 24. A stock can carry competitive moat that high while technicals sits at 24; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 98 |
| analyst consensus | 74 |
| technicals | 24 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Clene Inc. (CLNN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CLNN"><img src="https://stoquant.com/badge/CLNN.svg" alt="Clene Inc. (CLNN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.